{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:40:59Z","timestamp":1787913659331,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jocn.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T08:39:44Z","timestamp":1519202384000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"51","author":[{"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.02.011_b0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/11208120-000000000-00000","article-title":"Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions","volume":"14","author":"Garnock-Jones","year":"2012","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jocn.2018.02.011_b0010","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.jocn.2018.02.011_b0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: Anatomy, pathophysiology and treatment with emphasis on the role of Botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.jocn.2018.02.011_b0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S1679-45082016RB3594","article-title":"Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review","volume":"14","author":"Filho","year":"2016","journal-title":"Einstein (Sao Paulo)"},{"key":"10.1016\/j.jocn.2018.02.011_b0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.12912","article-title":"Salivary secretory disorders, inducing drugs, and clinical management","volume":"12","author":"Miranda-Rius","year":"2015","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jocn.2018.02.011_b0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.anorl.2010.12.010","article-title":"Ultrasound-guided botulinum toxin injections for treatment of drooling","volume":"128","author":"Breheret","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.jocn.2018.02.011_b0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0194599812465059","article-title":"Botulinum toxin for the treatment of sialorrhea: a meta-analysis","volume":"148","author":"Vashishta","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jocn.2018.02.011_b0040","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2018.02.011_b0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2018.02.011_b0050","unstructured":"Higgins JPT, Green S (ed.), Cochrane handbook for systematic reviews of interventions. 5.1.0 edition. Available from www.cochrane-handbook.org (last accessed on 1 May 2017)."},{"key":"10.1016\/j.jocn.2018.02.011_b0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jocn.2018.02.011_b0060","unstructured":"Van Rhee, HJ, Suurmond R, Hak T. User manual for Meta-Essentials: Workbooks for meta-analysis (Version 1.0) Rotterdam, The Netherlands: Erasmus Research Institute of Management. Available from http:\/\/www.erim.eur.nl\/research-support\/meta-essentials (accessed on 02 Jun 2017)."},{"key":"10.1016\/j.jocn.2018.02.011_b0065","unstructured":"Thorlund K, Engstrom J, Wetterslev J, Brok J, Imberger G, Gluud C. Trial sequential analysis. Copenhagen trial unit. Available at: http:\/\/www.ctu.dk\/tools-and-links\/trial-sequential-analysis.aspx (Accessed on 02 June 2017)."},{"key":"10.1016\/j.jocn.2018.02.011_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2008.09.001","article-title":"Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial","volume":"111","author":"Alrefai","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2018.02.011_b0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","article-title":"Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial","volume":"74","author":"Arbouw","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.02.011_b0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1469-8749.2011.03952.x","article-title":"Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses","volume":"53","author":"Basciani","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jocn.2018.02.011_b0085","first-page":"233","article-title":"Transdermal scopolamine in drooling","volume":"32","author":"Brodtkorb","year":"1988","journal-title":"J Ment Defic Res"},{"key":"10.1016\/j.jocn.2018.02.011_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-8749.1989.tb04000.x","article-title":"Efficacy of benztropine therapy for drooling","volume":"31","author":"Camp-Bruno","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jocn.2018.02.011_b0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.23929","article-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson\u2019s disease: a prospective double-blind trial","volume":"27","author":"Chinnapongse","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2018.02.011_b0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2018.02.011_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Herbelin L; Muscle Study Group. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2018.02.011_b0110","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2018.02.011_b0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2018.02.011_b0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jns.2011.05.021","article-title":"A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients","volume":"310","author":"Lloret","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2018.02.011_b0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study","volume":"154","author":"Mier","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jocn.2018.02.011_b0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.02.011_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0012-1622.2008.02010.x","article-title":"Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders","volume":"50","author":"Reid","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jocn.2018.02.011_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/TCRM.S26893","article-title":"Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions","volume":"8","author":"Zeller","year":"2012","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.jocn.2018.02.011_b0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/0883073810395391","article-title":"Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study","volume":"26","author":"Wu","year":"2011","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jocn.2018.02.011_b0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0028-1112115","article-title":"Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B","volume":"39","author":"Wilken","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jocn.2018.02.011_b0155","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/mds.21730","article-title":"Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease","volume":"22","author":"Thomsen","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2018.02.011_b0160","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03659.x","article-title":"Management of drooling in disabled patients with scopolamine patches","volume":"69","author":"Mato","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jocn.2018.02.011_b0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2018.02.011_b0170","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.02.011_b0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/NRE-2012-0781","article-title":"Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review","volume":"31","author":"Intiso","year":"2012","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.jocn.2018.02.011_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008624.pub2","article-title":"Interventions for drooling in children with cerebral palsy","volume":"11","author":"Walshe","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jocn.2018.02.011_b0185","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/adc.88.10.911","article-title":"A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling","volume":"88","author":"Jongerius","year":"2003","journal-title":"Arch Dis Child"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817320167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817320167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T10:58:29Z","timestamp":1603882709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817320167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":37,"alternative-id":["S0967586817320167"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.02.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}